a provider of immunotherapy products for the treatment of cancer and infectious diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CVM has been loosely correlated with EYPT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then EYPT could also see price increases.
Ticker / NAME | Correlation To CVM | 1D Price Change % | ||
---|---|---|---|---|
CVM | 100% | -11.11% | ||
EYPT - CVM | 36% Loosely correlated | -2.51% | ||
ATHE - CVM | 30% Poorly correlated | -0.85% | ||
RCKT - CVM | 29% Poorly correlated | -5.42% | ||
YMAB - CVM | 27% Poorly correlated | -12.06% | ||
PSTX - CVM | 26% Poorly correlated | -2.13% | ||
More |
Ticker / NAME | Correlation To CVM | 1D Price Change % |
---|---|---|
CVM | 100% | -11.11% |
drugs theme (254 stocks) | 23% Poorly correlated | -1.67% |
cancer theme (82 stocks) | 22% Poorly correlated | -2.35% |
diseases theme (41 stocks) | 16% Poorly correlated | -1.10% |
generic products theme (73 stocks) | 14% Poorly correlated | -0.43% |
biotechnology theme (238 stocks) | 14% Poorly correlated | -1.76% |
More |